Brief: Transcode Therapeutics Announces Expansion Of Global RNA Oncology Patent Portfolio
11/07/2022 21:44
July 11 (Reuters) - Transcode Therapeutics Inc RNAZ.O :
* TRANSCODE THERAPEUTICS ANNOUNCES EXPANSION OF GLOBAL RNA
ONCOLOGY PATENT PORTFOLIO
Source text for Eikon: ID:nGNX55lY5Q
Further company coverage: RNAZ.O
Recent news on Transcode Therapeutics
See all newsBrief: TransCode Therapeutics Appoints John Tattory As Interim CFO
Brief: Transcode Therapeutics Appoints Dr. Anna Moore As Chair Of Scientific Advisory Board
Brief: Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash
Brief: Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Brief: Transcode Therapeutics Expands Leadership With Appointment Of Jack E. Stover To Board Of Directors